Section of Hematology Oncology, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520-8063, USA.
Hematol Oncol Clin North Am. 2011 Apr;25(2):311-22, viii. doi: 10.1016/j.hoc.2011.01.005.
Microangiopathic disorders present with thrombocytopenia, hemolytic anemia, and multiorgan damage. In pregnancy, these disorders present a challenge both diagnostically and therapeutically, with widely overlapping clinical scenarios and disparate treatments. Although rare, a clear understanding of these diseases is important because devastating maternal and fetal outcomes may ensue if there is misdiagnosis and improper treatment. Microangiopathic disorders presenting in pregnancy are thus best assessed and treated by both obstetric and hematology teams. As a better understanding of the pathophysiology underlying each of the disease processes is gained, new diagnostic testing and therapies will be available, which will lead to improved outcomes.
微血管病性障碍表现为血小板减少、溶血性贫血和多器官损伤。在妊娠期间,这些疾病在诊断和治疗方面都带来了挑战,因为它们具有广泛重叠的临床情况和不同的治疗方法。虽然罕见,但如果误诊和治疗不当,可能会导致灾难性的母婴结局,因此,清楚地了解这些疾病非常重要。因此,妊娠中出现微血管病性障碍最好由产科和血液科团队共同评估和治疗。随着对每种疾病过程的病理生理学有了更好的理解,新的诊断测试和治疗方法将被开发出来,这将导致改善的结果。